Potential Clinical Value of Pretreatment De Ritis Ratio as a Prognostic Biomarker for Renal Cell Carcinoma

BACKGROUND: We performed this study to explore the prognostic value of the pretreatment aspartate transaminase to alanine transaminase (De Ritis) ratio in patients with renal cell carcinoma (RCC). METHODS: PubMed, EMBASE, Web of Science, and Cochrane Library were searched to identify all studies. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jinze, Cao, Dehong, Peng, Lei, Meng, Chunyang, Xia, Zhongyou, Li, Yunxiang, Wei, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724044/
https://www.ncbi.nlm.nih.gov/pubmed/34993141
http://dx.doi.org/10.3389/fonc.2021.780906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724044/
https://www.ncbi.nlm.nih.gov/pubmed/34993141
http://dx.doi.org/10.3389/fonc.2021.780906

Ejemplares similares